Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Columbia University |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000214 |
The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Buprenorphine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | IV Cocaine Abuse: A Laboratory Model |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
Study ID Numbers: | NIDA-06234-3, R01-06234-3 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000214 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Buprenorphine Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Cocaine |
Sensory System Agents Therapeutic Uses Narcotic Antagonists Physiological Effects of Drugs Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions Analgesics, Opioid |